MedStar Health: Stem Cell Transplant and Cellular Immunotherapy Program at MedStar Georgetown University Hospital

Our Stem Cell Transplant and Cellular Immunotherapy Program is the only adult, FACT-accredited institution in the Washington, D.C., area for both allogeneic and autologous transplantation as well as CAR-T cell—a recognition that indicates our program has met the standards of excellence in stem cell therapy.  We give patients with cancers affecting the blood or immune system and other disorders access to life-saving treatment options not otherwise available in our region. These include:

• Allogeneic stem cell transplant

• Autologous stem cell transplant

• CAR T-cell therapy

Our specialists have extensive experience performing these complex procedures safely, effectively, and comfortably. Our program features:

• Experienced and dedicated specialists

• Expertise with high-risk patients

• A dedicated 18-bed stem cell transplant, oncology, and hematology unit staffed by specialty-trained nurses

• Holistic care, with training for caregivers

• The nation's largest marrow harvesting site

• State-of-the-art transplant clinic with bright, beautifully decorated space

Our research engine, Georgetown Lombardi Comprehensive Cancer Center, the only National Cancer Institute (NCI)-designated comprehensive cancer center in the Washington, D.C., region, provides access to clinical trials as well as breakthrough treatment options. Together, we deliver comprehensive, advanced care to our patients.

We are also proud of our close collaboration with the John Theurer Cancer Center at Hackensack University Medical Center–one of the nation’s ten largest programs.